Susannah Gray, MBA
Directorat4D Molecular Therapeutics· In proxies 2023–2025
Susannah Gray, MBA sits on 14 public boards.
Boards1
- 4D Molecular TherapeuticsDirector · 5 yr on the boardIndependentAudit (Chair), Compensation (Chair)—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- 4D Molecular TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -36%
- AnaptysBio, Inc.Public company · Less than 1 yr
- Director2026 – Present · Less than 1 yrNo stock prices for these years
- Theravance BioPharma, Inc.Public company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Morphic TherapeuticPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Maravai LifeSciences Holdings, Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- BioSplice LLCPublic company
- Director? – PresentNo stock prices for these years
- German Marshall FundPublic company
- Director? – PresentNo stock prices for these years
- Hidden Pigeon CompanyPublic company
- Director? – PresentNo stock prices for these years
- Maravai Life SciencesPublic company
- Director? – PresentNo stock prices for these years
- StreetSquashPublic company
- Director? – PresentNo stock prices for these years
- Susan GPublic company
- Director? – PresentNo stock prices for these years
- Apria, Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Morphic Holding, Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- BioSplice Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?